Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment

E. Papakonstantinou, I. Klagas, G. Karakiulakis, S. Savic Prince, M. Roth, M. Tamm, D. Stolz (Basel, Switzerland; Thessaloniki, Greece)

Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Session: New studies into pulmonary proteases and antiproteases
Session type: Oral Presentation
Number: 4855
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Papakonstantinou, I. Klagas, G. Karakiulakis, S. Savic Prince, M. Roth, M. Tamm, D. Stolz (Basel, Switzerland; Thessaloniki, Greece). Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment. Eur Respir J 2014; 44: Suppl. 58, 4855

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Acute exacerbations in COPD patients are associated with increased levels of hyaluronic acid and heparan sulfate in BAL
Source: International Congress 2014 – Translational studies in COPD
Year: 2014

Pulmonary and systemic inflammation in patients with AECOPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

Cellular composition of bronchoalveolar lavage (BAL) as inflammation indicator in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Diagnostic and therapeutic bronchoscopy: old and new techniques for interventional pulmonology
Year: 2014


Expression of matrix metalloproteinases in bronchoalveolar cells in COPD and in COPD phenotypes
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015


Targeting PI3KΔ or JAK in T-cells from COPD and severe asthma subjects reduces corticosteroid insensitive inflammatory responses
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

Glycosaminoglycans significantly correlate with matrix metalloproteinases during exacerbations of COPD
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015

Periostin in lower airway samples and serum, a novel asthma marker?
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015


The use of bronchoalveolar lavage (BAL) to assess lower airways inflammation in asthma
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016


Sampling the lung fluids: peripheral biomarkers
Source: Annual Congress 2007 - Pulmonary biomarkers in COPD
Year: 2007


Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014

Lung microbiome is associated with asthma severity in fungal associated asthma
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015


Bronchoalveolar lavage tryptase levels are correlated with type 2 airway inflammation in mild asthma
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015


Changes of IL-6 level in bronchoalveolar fluid in patients with acute exacerbation of COPD before and after the treatment with tiotropium bromide, and its significance
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

Neutrophil numbers are decreased in bronchial biopsies from patients with COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

Profiling the proteome of the lower airway respiratory tract lining fluid in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013


Diagnostic implications of sTREM-1 in induced sputum and BAL fluid of patients with asthma and COPD
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015

Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014

Differential bronchoalveolar expression of candidate microRNAs in chronic obstructive pulmonary disease, asthma bronchiale and pulmonary sarcoidosis
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014

Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation
Source: Eur Respir J 2005; 25: 447-454
Year: 2005



Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid
Source: Eur Respir J 2004; 24: 964-970
Year: 2004